MDBH vs EXOZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

MDBH

52.2
AI Score
VS
MDBH Wins

EXOZ

49.9
AI Score

Investment Advisor Scores

MDBH

52score
Recommendation
HOLD

EXOZ

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MDBH EXOZ Winner
Net Income -16.05M -2.04M EXOZ
Operating Income -508,000 -1.80M MDBH
ROE -32.3% 530.4% EXOZ
ROA -31.6% -57.3% MDBH
Total Assets 50.77M 3.56M MDBH
Cash 9.58M 66,533 MDBH
Free Cash Flow -5.57M -1.47M EXOZ

Relative Price Performance (Last 90 Days)

MDBH 1M: -35.6% · 3M: -47.2% EXOZ 1M: -36.9% · 3M: -12.1%

Current Technical Phase

MDBH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -14.1%), weak momentum, RSI 29

RSI (14): 28.7 · Price: $1.72

EXOZ

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.0%), weak momentum, RSI 25

RSI (14): 25.5 · Price: $4.00

Fundamentals Snapshot

Metric MDBH EXOZ
Market Cap — —
Forward P/E 0.0 -3.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.9% 0.0%
Gross Margin 0.7% 1.0%
Operating Margin 11.1% 0.0%
EPS -2.14 -1.19
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MDBH is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.